Browse 472 Federal Consumer Protection Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Consumer Protection grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
January 25th, 2022 |
Renewal - Cooperative Agreement to Support the Joint Institute for Food Safety and Applied Nutrition, JIFSAN (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
February 3rd, 2022 |
FY 2022 AmeriCorps Seniors - American Rescue Plan Senior Demonstration Program |
AmeriCorps |
October 28th, 2021 |
Pool Safely Grant Program |
Consumer Product Safety Commission |
March 31st, 2022 |
Physiologically Based Pharmacokinetic Model for Nose-to-Brain Drug Delivery (U01) Clinical Trial Optional |
Food and Drug Administration |
March 7th, 2022 |
Development of advanced analytical methods for the characterization of complex generics |
Food and Drug Administration |
March 31st, 2022 |
PBPK modeling to support assessment of bioequivalence of locally acting drugs in the gastrointestinal tract |
Food and Drug Administration |
March 31st, 2022 |
Investigating the in vivo behavior and in vitro characteristics purportedly gastro-retentive extended release formulation to enhance the regulatory standard of such products |
Food and Drug Administration |
March 31st, 2022 |
In Vitro Based Approaches to Evaluate the Bioequivalence of Generic Rectal and Vaginal Products |
Food and Drug Administration |
March 31st, 2022 |
Cutaneous pharamcokinetic-based approaches to establish bioequivalence of topically applied drug products |
Food and Drug Administration |
June 30th, 2022 |
Innovative ways to provide education on antimicrobial stewardship practices in animals. |
Food and Drug Administration |
April 2nd, 2022 |
Research to support the development of alternatives to antimicrobials for use in food-producing animals |
Food and Drug Administration |
November 29th, 2021 |
Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Optional |
Food and Drug Administration |
February 9th, 2024 |
CVM Vet-LIRN Veterinary Diagnostic Laboratory Program (U18) Clinical Trials |
Food and Drug Administration |
April 11th, 2022 |
Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks and Pediatric Anesthesia Safety Initiative (ACTTION/PASI) (U01) Clinical Trial Not Allowed) |
Food and Drug Administration |
October 3rd, 2022 |
Academic Development of a Training Program for Good Laboratory Practices in High Containment Environments (U24) Clinical Trials Not Allowed |
Food and Drug Administration |
July 6th, 2021 |
Enhance Uniformity of Traffic Laws and Countermeasures Among State Motor Vehicle Administrators Offices |
National Highway Traffic Safety Administration |
August 16th, 2021 |
Pool Safely Grant Program (PSGP) |
Consumer Product Safety Commission |
July 6th, 2021 |
Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trials Not Allowed |
Food and Drug Administration |
July 6th, 2021 |
Pediatric and Perinatal COVID-19 Registry (U18) Clinical Trials Optional |
Food and Drug Administration |
May 24th, 2021 |
SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership (PPP) under PASI (Pediatric Anesthesia Safety Initiative) (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
|
July 13th, 2021 |
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
May 28th, 2021 |
AAV Vector manufacturing for diseases affecting very small populations (R01) Clinical Trials Not Allowed |
Food and Drug Administration |
June 14th, 2021 |
Strategies that Support Global Food Safety (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
May 24th, 2021 |
Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
May 18th, 2021 |
Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trials Not Allowed |
Food and Drug Administration |
May 17th, 2021 |
Expanding the opioids system modeling efforts to more comprehensively address fentanyl, stimulants use, polysubstance use and associated outcomes.(U01) Clinical Trials Not Allowed |
Food and Drug Administration |
June 2nd, 2021 |
Data Standards for Tobacco Research and Scientific Review Program (U24) Clinical Trial Not Allowed |
Food and Drug Administration |
May 14th, 2021 |
AAV Vector manufacturing for diseases affecting very small populations |
Food and Drug Administration |
May 14th, 2021 |
Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases |
Food and Drug Administration |
April 26th, 2021 |
Impulse Oscillometry Endpoint Sensitivity to Regional Lung Function Changes using Computational Fluid Dynamics (CFD) (U01) Clinical Trial Required |
Food and Drug Administration |
March 1st, 2023 |
The FDA's Cooperative Agreement Program for States and Territories to Implement a National Produce Safety Program (U2F) Clinical Trials Not Allowed |
Food and Drug Administration |
February 2nd, 2024 |
Minor Use Minor Species Development of Drugs (R01) |
Food and Drug Administration |
May 3rd, 2023 |
Drug Development Tools Research Grants (U01) Clinical Trial Optional |
Food and Drug Administration |
April 23rd, 2021 |
Alliance to Support Integrated Food Safety System (IFSS) Activities (U2F) Clinical Trials Not Allowed |
Food and Drug Administration |
May 25th, 2021 |
Renewal : UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (U01) Clinical Trials Optional |
Food and Drug Administration |
April 22nd, 2021 |
Dermal Physiologically-based Pharmacokinetic (PBPK) Models Accounting for the Absorption and Evaporation of Vehicle/Co-solvent following the Application of Generic Dermatological Products (U01) |
Food and Drug Administration |
April 19th, 2021 |
Training Alliance to Enhance Produce Safety and FDA Food Safety Modernization Act Compliance (U2F) Clinical Trial Not Allowed |
Food and Drug Administration |
March 31st, 2021 |
FY2021 U.S. Embassy Tokyo: Alumni Capacity Building |
US Mission to Japan |
March 22nd, 2021 |
Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) by State, Local, Tribal, and Territorial (SLTT) Retail Food Regulatory Agencies (U2F) Clinical Trials Not Allowed |
Food and Drug Administration |
March 18th, 2021 |
Renewal - Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations (U01) Clinical Trial Required |
Food and Drug Administration |